- Home
- / Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group
Stock Price
$20.5
2024-10-29
Market Capitalization
$108.8 B
2024-10-29
Revenue
¥10.1 B
FY, 2023
Jiangsu Hansoh Pharmaceutical Group Summary
Company Summary
- Overview
- Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company. It is committed to innovation and research in the six therapeutic areas including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular.
- Type
- Public
- Status
- Active
- Founded
- 1995
- HQ
- Lianyungang Shi, CN | view all locations
- Website
- http://www.hansoh.cn/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Lianyungang Shi, Jiangsu Sheng HQ
China
Dong Jin Lu & Hua Guo Shan Da Dao, Lianyun Qu
Jiangsu Hansoh Pharmaceutical Group Financials
Summary Financials
- Revenue (FY, 2023)
- ¥10.1B
- Gross profit (FY, 2023)
- ¥9.5B
- Net income (FY, 2023)
- ¥3.3B
- Cash (FY, 2023)
- ¥22.4B
- EBIT (FY, 2023)
- ¥2.7B
- Enterprise value
- $90.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2024